International Journal of Clinical Biochemistry and Research

Print ISSN: 2394-6369

Online ISSN: 2394-6377

CODEN : IJCBK6

International Journal of Clinical Biochemistry and Research (IJCBR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 209

PDF Downloaded: 110


Get Permission Veeranki, Kiran, and Kiran: Comparison of degree of endothelial dysfunction in diabetic patients with and without dyslipidemia


Introduction

Diabetes mellitus is a serious global health problem and is expected to become worse. The frequencies of coronary heart disease, stroke and peripheral vascular disease are all about 2-4% higher in either type 1 or in type 2 diabetes compared with the general population.1 Atherosclerosis in patients with type 2 diabetes is multifactorial and includes a very complex interaction, including hyperglycemia, hyperlipidemia, oxidative stress, accelerated aging, hyperinsulinemia, and/or hyperproinsulinemia and alterations in coagulation and fibrinolysis.2, 3, 4 A current hypothesis for the initial lesion in atherosclerosis involves changes in the endothelial cell function. Assessment of endothelial function, thus, can provide valuable insight into the pre-intrusive phase of atherosclerosis and can be used as an early marker of future atherosclerotic disease. However, the invasive nature of the earlier available tests for assessment of endothelial function precluded their use in clinical practice. The development of a non-invasive method of assessment of endothelial function by brachial artery flow-mediated vasodilatation (FMD), as described by Celermajer, provided an extremely useful tool for cardiovascular research and for clinical application.5, 6, 7 This test can be performed easily and has proven reproducibility.8

Among other factors, dyslipidemia and increased levels of oxidized LDL are important pathogenic mechanisms of endothelial dysfunction in patients with diabetes. Since it has been shown that treatment of dyslipidemia with drugs improves endothelial function in non-diabetic, dyslipidemic individuals, it becomes very tempting to extrapolate the conclusions from these findings to the diabetic population.9, 10, 11

In view of the above-stated facts, the present study aims to demonstrate and determine whether impairment in endothelial function occurs in patients with type 2 diabetes mellitus. It also aims to determine whether there is an increased dysfunction of the endothelium in the presence of diabetes mellitus with dyslipidemia.

Materials and Methods

90 patients attending the medicine and endocrinology departments at KGH during the period from Sep 2009 to Oct 2010 were included in the study. Inclusion criteria include patients with Diabetes mellitus diagnosed by the ADA criteria and patients with dyslipidemia categorized as per the NCEP ATP-III guidelines. Informed consent was obtained from all the study subjects. Patients with the presence of clinically evident micro/macrovascular complications of diabetes have been excluded. The presence of clinically evident micro/ macrovascular complications was excluded by using clinical or ECG evidence of CAD, past or present history of stroke or TIA, clinical evidence of peripheral vascular disease, features suggestive of diabetic retinopathy on fundus examination, presence of overt proteinuria or serum creatinine > 2mg/dL and clinical evidence of diabetic neuropathy.

Clinical examination included blood pressure measurement, cardiovascular examination, and body mass index (BMI). Plasma glucose, serum cholesterol, serum triglycerides, and high-density lipoprotein-cholesterol (HDL-C) were estimated. LDL-cholesterol (LDL-c) was calculated using the Friedewald formula.

The brachial artery diameter was measured on B-mode ultrasound images. The right brachial artery was studied in all the subjects. A resting scan was obtained, and the velocity of arterial flow was measured with a pulsed Doppler signal at a 700 angle to the vessel, with the range gate (1.5 mm) in the center of the artery. Increased flow was then induced by the inflation of a sphygmomanometer cuff placed around the forearm (distal to the scanned part of the artery) to a pressure of 200 mmHg for 4.5 minutes, followed by release. A second scan was performed continuously for 30 seconds before and 90 seconds after the deflation of the cuff, including a repeated recording of flow velocity for the first 15 seconds after the cuff was released.

FMD was calculated, and the average results of the two observations were recorded. Flow-mediated dilatation was presented as the percent change from baseline to hyperemia. Severe endothelial dysfunction was defined as FMD < 4.5%, as has been described.

Calculation of FMD

FMD = (d2-d1) x 100/d1

Where,

d1 is the brachial artery diameter at baseline

d2 is the brachial artery diameter at 1 minute of cuff release

Reactive hyperemia was established by an increase in peak systolic velocity (PSV) from baseline to immediately after cuff release.

Statistical analysis

Data were collected and managed on an Excel worksheet. All values are expressed as mean ± SD. The unpaired Student's t-test was used to compare the mean of continuous variables. The correlation coefficient was used to determine if an association existed among diabetes, dyslipidemia, and endothelial function. P values ≤ 0.05 were considered significant.

Figure 1

Normal dilatation of brachial artery from baseline to 90 sec after cuff release

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/2c889943-f12b-4129-a311-1447e18650d5/image/c8da8ce9-7728-413f-af64-4cde37f2db83-ufig-1-8th-august-2024.jpg
Figure 2

Presence of reactive hyperemia as shown by the increase in peak systolic velocity

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/2c889943-f12b-4129-a311-1447e18650d5/image/d53068d9-8fd9-43c0-af88-0ca1e6e8abe0-ufig-12345.jpg
Figure 3

Increased diameter of brachial artery from baseline to 90 sec after cuff release

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/2c889943-f12b-4129-a311-1447e18650d5/image/4987457e-625d-4962-bd22-f42f7e96460e-ufig-4-8th-aug-2024.jpg
Figure 4

Presence of reactive hyperemia as shown by the increase in peak systolic velocity

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/2c889943-f12b-4129-a311-1447e18650d5/image/b2263379-96d5-406f-8b5a-cdc7e7400ac2-ufile-n.jpg
Figure 5

Complete absence of dilatation of brachial artery from baseline to 90 sec after cuff release

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/2c889943-f12b-4129-a311-1447e18650d5/image/cdf80e34-333a-4861-9277-4dcf3b54cfad-ufig-6-8th-july-2024.jpg
Figure 6

Complete absence of dilatation of brachial artery from baseline to 90 sec after cuff release

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/2c889943-f12b-4129-a311-1447e18650d5/image/aa8c16ce-4689-430f-8dc6-553ce23e5207-ufig-7-8th-july-2024.jpg
Figure 7

Presence of reactive hyperemia as shown by the increase in PSV

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/2c889943-f12b-4129-a311-1447e18650d5/image/d443ec7e-c5a6-4d2d-ad06-f9b53937fcf6-ufig-9-8th-july-2024.jpg

Results

In the present study, 30 controls and 60 cases were taken. Cases were further stratified into two groups. Diabetics with dyslipidemia were one group (n=34), and those without dyslipidemia were the other group (n=26). The presence of diabetes mellitus, as diagnosed by the ADA criteria. Presence of dyslipidemia as per the NCEP ATP–III guidelines.

Table 1

Age distribution of cases

31-40 yr

41-50 yr

51-60 yr

61-70 yr

Males

2

14

18

2

Females

2

8

14

0

Table 2

Age distribution of controls

41-50 yr

51-60 yr

Males

8

10

Females

2

10

Most of the subjects are in the 51-60 years age group. Controls were 20 (66.67%), and cases were 32 (53.33%).

Table 3

Baseline clinical characteristics in the study population

S. No.

Variable

Controls

Cases

p-value

1

Age

51.6±3.43

51.13±5.48

<0.7

2

BMI

23.52±3.16

24.55±3.93

<0.3

3

TC

172.26±20.00

191.13±44.63

<0.05

4

HDL-C

45.9±5.33

43.06±9.96

<0.21

5

LDL-C

92.26±17.35

120.03±35.76

<0.0001

6

TG

170.26±17.35

164.26±83.0

<0.7

7

TC/HDL

3.76±0.43

4.81±2.18

<0.01

[i] BMI: Body mass index, TC: Total cholesterol, HDL: High density lipoprotein, LDL-c: Low density lipoprotein cholesterol, TG: Triglycerides.

A baseline comparison of lipid profiles between the diabetes group and the control group showed 1) elevated BMI, 2) elevated total cholesterol, 3) lowered HDL-C, 4) elevated LDL-C, and 5) lowered TG in the diabetes group. Of these, the increase in TC and LDL was found to be statistically significant.

Table 4

Comparison of lipid profile between diabetics with and without dyslipidemia

S. No.

Variable

Diabetes without dyslipidemia

Diabetes with dyslipidemia

p-value

1

Age

53.61±5.51

49.23±4.77

<0.03

2

BMI

21.61±3.01

26.79±2.99

<0.0001

3

TC

168.92±33.76

208.11±45.25

<0.01

4

HDL-C

50.46±5.09

37.41±9.06

<0.001

5

LDL-C

99.30±22.41

135.88±36.41

<0.002

6

TG

92.23±21.97

219.36±70.56

<0.0001

7

TC/HDL

3.35±0.61

5.74±2.3

<0.0002

[i] BMI: Body mass index, TC: Total cholesterol, HDL: High density lipoprotein, LDL-c: Low density lipoprotein cholesterol, TG: Triglycerides.

When a comparison was made between diabetes with dyslipidemia and diabetes without dyslipidemia, the following differences were observed:

  1. The average age of the dyslipidemia group was lower.

  2. They had a higher body mass index.

  3. There was an elevated TC, elevated LDL-C, TG, TC/HDL-C, and decreased HDL-C levels.

  4. All the values were statistically significant.

Table 5

Comparison of FMD between cases and controls

S. No.

Variable

Controls

Cases

p-value

1

FMD

14.76±2.17

7.17±5.1

<0.0001

Table 6

Comparison of FMD between diabetes with and without dyslipidemia

S. No.

Variable

Diabetes without dyslipidemia

Diabetes with dyslipidemia

p-value

1

FMD

9.82±4.39

5.74±5.02

<0.02

The average FMD among controls was 14.76±2.17%, and among diabetics was 7.17±5.1%. Within the dyslipidemia subgroup, FMD was markedly reduced with an average dilatation of 5.74±5.02.

Table 7

Prevalence of endothelial dysfunction in the cases and controls

Variable

Controls (n=30)

Cases (n=60)

Normal lipid profile (n=26)

Dyslipidemia group (n=34)

FMD <4.5

0 (0%)

16 (26%)

2 (14%)

14 (41%)

FMD >4.5

30 (100%)

44 (74%)

24 (92%)

20 (59%)

Severe endothelial dysfunction was prevalent in 26% of the diabetics. Endothelial dysfunction could not be demonstrated in controls. Among patients with diabetic dyslipidemia, the prevalence of ED was 41%.

Table 8

Correlation of FMD with diabetic dyslipidemia on univariate analysis

S. No.

Variable

r-value

p-value

1

AGE

-0.54

>0.001

2

BMI

-0.43

>0.0001

3

TC

-0.37

>0.005

4

HDL

+0.0001

Not significant

5

LDL

-0.32

>0.05

6

TG

-0.63

>0.0001

7

TC/HDL

-0.25

Not significant

[i] BMI: Body mass index, TC: Total cholesterol, HDL: High density lipoprotein, LDL-c= Low density lipoprotein cholesterol, TG: Triglycerides.

A significant negative correlation is seen between age, BMI, TC, LDL-C, TG, and the extent of endothelial dysfunction.

Discussion

In the present study, there was an impairment of flow-mediated dilatation in diabetics when compared with normal subjects (7.17±5.1 vs. 14.76±2.17, p-value <0.0001). Within the diabetes group, patients with dyslipidemia had shown significant impairment in FMD than patients without dyslipidemia (5.74±5.02 vs. 9.82±4.39, p-value <0.02). A significant negative correlation was found between TC, LDL-C, TG, and TC/HDL ratio and the degree of impairment of endothelial function.

Similar results were obtained in other studies. In a study by K. Bhargava et al., significant endothelial dysfunction was observed in diabetes (5.51±2.21%) when compared with normal subjects (7.03±2.87%).12 They have shown that a similar degree of endothelial dysfunction occurred in patients with CAD without diabetes mellitus (4.56±2.7%). In a similar study conducted by Uday Jadhav et al., significant impairment of endothelial function occurred in diabetics when compared with non-diabetics (p-value <0.05).13 They also showed that endothelial dysfunction was more prevalent in the dyslipidemia group. However, their values were not statistically significant.

Clarkson et al., in their study, have shown that endothelial function was significantly impaired in diabetics as compared to controls (5.0±3.7 vs 9.3±3.8%, p-value <0.001).14, 15, 16, 17 Similarly, Yu HI et al. have demonstrated that FMD of the brachial artery was significantly impaired in diabetes. The impairment was more marked in the presence of peripheral arterial disease, dyslipidemia, and diabetic complications.18

Yerong Yu et al. have shown that compared with type 2 diabetes patients with normoalbuminuria, patients with microalbuminuria had more prominent endothelial dysfunction (9.7±4.3 vs. 8.0±3.8%, p-value <0.05).19 Antonaides et al. have shown that endothelial function was better in healthy controls when compared with patients with diabetes and CAD (p-value <0.001) or patients with diabetes alone (p-value <0.001).20 They have also shown that vitamin C, which acts as an antioxidant, has improved the forearm vasodilatory response.

Advantages of the study

Assessment of endothelial function using the FMD technique is a simple, economical, noninvasive, widely available test that can be used for both diagnostic and therapeutic purposes. However, the major limitation of the present study is that the technique is relatively new, and the patients taken into each study are few in number.

Limitations of the study

Though low HDL level in diabetes, which is proven to cause endothelial dysfunction, was associated with impairment of endothelial function in this study, it did not show a statistically significant independent effect. This may be due to the small sample size. This is not a cohort study and a long follow-up of the subjects is required to permit a statistically confirmed statement regarding the prediction of future atherosclerotic events based on endothelial dysfunction.

Some of the cases were on pharmacological treatment for diabetes and dyslipidemia with drugs that are proven to improve endothelial function (e.g., Metformin, Statins). This could be a confounding factor in the present study.

Suggestions for the future

The study results emphasize the importance of early detection and control of vascular risk factors in type 2 diabetes because these people are at particular risk for developing early structural atherosclerotic changes. The ultrasound assessment of arterial FMD responses might provide a valuable tool for risk stratification of patients with type 2 diabetes, especially for those with dyslipidemia.21, 22 In parallel, new developments in the field of DNA array technologies will help to identify target genes important for different phases of atherosclerosis. These developments may replace mere angiographic detection of vascular disease with a more functional and genomic approach with the perspectives to evaluate new strategies in risk stratification and treatment.

Summary and Conclusions

The development of the non-invasive method of endothelial function assessment by flow-mediated vasodilatation (FMD) provided an extremely useful tool for cardiovascular research and for clinical application. A close correlation of endothelial function in the human coronary and peripheral vasculature has been demonstrated. Ultrasonography is a reliable and accurate technique to determine flow-mediated dilatation in the superficial arteries. Reproducibility of FMD determination is best in the brachial artery in healthy subjects and in patients with atherosclerosis. B-mode ultrasound scan, including brachial artery FMD, may be of clinical value in the screening for endothelial dysfunction.

Given the paucity of facilities and financial constraints for evaluation of endothelial function in India, measurement of endothelial dysfunction using a non-invasive method like brachial artery FMD acts as an attractive prospect. Longitudinal studies involving a large number of people are required to demonstrate the utility of this test as a predictor of atherosclerosis in diabetes in Indian population.

Source of Funding

None.

Conflict of Interest

None.

References

1 

E Standl B Balletshofer, B Dahl B Weichenhain H Stiegler A Hörmann Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner ProjectDiabetologia19963915405

2 

F Cosentino TF Luscher Endothelial dysfunction in diabetes mellitusJ Cardiovasc Pharmacol199832Suppl 3S5461

3 

DS Celermajer KE Sorensen VM Gooch DJ Spiegelhalter OI Miller ID Sullivan Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisLancet1992340882811115

4 

P Andersen I Seljeflot M Abdelnoor H Arnesen PO Dale A Løvik Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndromeMetab19954456116

5 

TJ Anderson E Elstein H Haber F Charbonneau Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)J Am Coll Cardiol2000351606

6 

MC Corretti TJ Anderson EJ Benjamin D Celermajer F Charbonneau MA Creager Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task ForceJ Am Coll Cardiol200239225765

7 

CG Schalkwijk CD Stehouwer Vascular complications in diabetes mellitus: The role of endothelial dysfunctionClin Sci (Lond)2005109214359

8 

KE Sorensen DS Celermajer DJ Spiegelhalter D Georgakopoulos J Robinson O Thomas Non-invasive measurement of human endothelium dependent arterial responses: Accuracy and reproducibility accuracy and reproducibilityBr Heart J199574324753

9 

F Fiordaliso Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozocin-induced diabetesLife Sci200679121130

10 

H E Tawfik Simvastatin improves diabetes-induced coronary endothelial dysfunctionJ Pharmacol Exp Ther200631938695

11 

LA Simons D Sullivan J Simons DS Celermajer Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemiaAtheroscler19981371197203

12 

K Bhargava G Hansa M Bansal S Tandon RR Kasliwal Endothelium-dependent brachial artery flow mediated vasodilatation in patients with diabetes mellitus with and without coronary artery diseaseJ Assoc Physicians India2003513558

13 

UM Jadhav A Sivaramakrishnan NN Kadam Noninvasive assessment of endothelial dysfunction by brachial artery flow-mediated dilatation in prediction of coronary artery disease in Indian subjectsIndian Heart J2003551448Indian Heart J

14 

P Clarkson DS Celermajer AE Donald M Sampson KE Sorensen M Adams Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levelsJ Am Coll Cardiol19962835739

15 

RP Gray A Panahloo V Mohamed-Ali DL Patterson JS Yudkin Proinsulin-like molecules and plasminogen activator inhibitor type 1 (PAI-1) activity in diabetic and non-diabetic subjects with and without myocardial infarctionAtheroscler19971301-21718

16 

J Calles-Escandon SA Mirza BE Sobel DJ Schneider Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjectsDiabetes19984722903

17 

A Kouroedev M Eto H Joch M Volpe TF Lüscher F Cosentino Selective inhibition of protein kinase C beta 2 prevents acute effects of high glucose on Vascular cell adhesion molecule-1 expression in human endothelial cellsCirc20041101916

18 

HI Yu WH Sheu CJ Lai WJ Lee YT Chen Endothelial dysfunction in type 2 diabetes mellitus subjects with peripheral artery diseaseInt J Cardiol20017811925

19 

Y Yu L Suo H Yu C Wang H Tang Insulin resistance and endothelial dysfunction in type 2 diabetes with and without microalbuminuriaDiabetes Res Clin Pract200465295104

20 

C Antoniades D Tousoulis C Tountas C Tentolouris M Toutouza C Vasiliadou, Vascular endothelium and inflammatory process, in patients with combined type 2 diabetes and coronary atherosclerosis: Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: The effects of vitamin CDiabet Med20042165528

21 

KE Sorensen IB Kristensen DS Celermajer Atherosclerosis in the human brachial arteryJ Am Coll Cardiol199729231822

22 

TJ Anderson A Uehata MD Gerhard IT Meredith S Knab D Delagrange Close relation of endothelial function in the human coronary and peripheral circulationsJ Am Coll Cardiol1995265123541



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Original Article


Article page

93-99


Authors Details

Sandeesha Veeranki, Ravi Kiran, Usha Kiran


Article History

Received : 11-07-2024

Accepted : 30-07-2024


Article Metrics


View Article As

 


Downlaod Files